Aprogen Medicines Inc. (KRX:007460)
South Korea flag South Korea · Delayed Price · Currency is KRW
751.00
-1.00 (-0.13%)
Last updated: Mar 27, 2025

Aprogen Medicines Revenue

In the year 2024, Aprogen Medicines had annual revenue of 150.11B KRW, down -0.31%. Aprogen Medicines had revenue of 39.65B in the quarter ending December 31, 2024, with 6.05% growth.

Revenue
150.11B
Revenue Growth
-0.31%
P/S Ratio
1.27
Revenue / Employee
612.71M
Employees
245
Market Cap
214.81B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024150.11B-464.40M-0.31%
Dec 31, 2023150.58B72.23B92.19%
Dec 31, 202278.35B52.05B197.95%
Dec 31, 202126.30B-100.85B-79.32%
Dec 31, 2020127.14B48.89B62.48%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition